Literature DB >> 35768755

Investigating longitudinal changes to frontal cortico-striatal tracts in Huntington's disease: the IMAGE-HD study.

Brendan Tan1, Rosita Shishegar1,2,3, Stuart Oldham3,4, Alex Fornito1,3, Govinda Poudel1,5,6, Nellie Georgiou-Karistianis7.   

Abstract

The striatum is the principal site of disease pathology in Huntington's disease and contains neural connections to numerous cortical brain regions. Studies examining abnormalities to neural connections find that white matter integrity is compromised in HD; however, further regional, and longitudinal investigation is required. This paper is the first longitudinal investigation into region-based white-matter integrity changes in Huntington's Disease. The aim of this study was to better understand how disease progression impacts white matter tracts connecting the striatum to the prefrontal and motor cortical regions in HD. We used existing neuroimaging data from IMAGE-HD, comprised of 25 pre-symptomatic, 27 symptomatic, and 25 healthy controls at three separate time points (baseline, 18-months, 30-months). Fractional anisotropy, axial diffusivity and radial diffusivity were derived as measures of white matter microstructure. The anatomical regions of interest were identified using the Desikan-Killiany brain atlas. A Group by Time repeated measures ANCOVA was conducted for each tract of interest and for each measure. We found significantly lower fractional anisotropy and significantly higher radial diffusivity in the symptomatic group, compared to both the pre-symptomatic group and controls (the latter two groups did not differ from each other), in the rostral middle frontal and superior frontal tracts; as well as significantly higher axial diffusivity in the rostral middle tracts only. We did not find a Group by Time interaction for any of the white matter integrity measures. These findings demonstrate that whilst the microstructure of white matter tracts, extending from the striatum to these regions of interest, are compromised during the symptomatic stages of Huntington's disease, 36-month follow-up did not show progressive changes in these measures. Additionally, no correlations were found between clinical measures and tractography changes, indicating further investigations into the relationship between tractography changes and clinical symptoms in Huntington's disease are required.
© 2022. The Author(s).

Entities:  

Keywords:  Diffusion tensor imaging; Huntington’s disease; Tractography; White matter

Year:  2022        PMID: 35768755     DOI: 10.1007/s11682-022-00699-6

Source DB:  PubMed          Journal:  Brain Imaging Behav        ISSN: 1931-7557            Impact factor:   3.978


  35 in total

1.  Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. 1996.

Authors:  Peter J Basser; Carlo Pierpaoli
Journal:  J Magn Reson       Date:  2011-12       Impact factor: 2.229

Review 2.  Motor functions of the parietal lobe.

Authors:  Leonardo Fogassi; Giuseppe Luppino
Journal:  Curr Opin Neurobiol       Date:  2005-11-03       Impact factor: 6.627

3.  An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest.

Authors:  Rahul S Desikan; Florent Ségonne; Bruce Fischl; Brian T Quinn; Bradford C Dickerson; Deborah Blacker; Randy L Buckner; Anders M Dale; R Paul Maguire; Bradley T Hyman; Marilyn S Albert; Ronald J Killiany
Journal:  Neuroimage       Date:  2006-03-10       Impact factor: 6.556

4.  Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease.

Authors:  Eve M Dumas; Simon J A van den Bogaard; Margot E Ruber; Ralf R Reilman; Julie C Stout; David Craufurd; Stephen L Hicks; Chris Kennard; Sarah J Tabrizi; Mark A van Buchem; Jeroen van der Grond; Raymund A C Roos
Journal:  Hum Brain Mapp       Date:  2011-01-24       Impact factor: 5.038

5.  Frontal lobe volume in patients with Huntington's disease.

Authors:  E H Aylward; N B Anderson; F W Bylsma; M V Wagster; P E Barta; M Sherr; J Feeney; A Davis; A Rosenblatt; G D Pearlson; C A Ross
Journal:  Neurology       Date:  1998-01       Impact factor: 9.910

6.  Automated differentiation of pre-diagnosis Huntington's disease from healthy control individuals based on quadratic discriminant analysis of the basal ganglia: the IMAGE-HD study.

Authors:  N Georgiou-Karistianis; M A Gray; J F Domínguez D; A R Dymowski; I Bohanna; L A Johnston; A Churchyard; P Chua; J C Stout; G F Egan
Journal:  Neurobiol Dis       Date:  2012-10-13       Impact factor: 5.996

Review 7.  Structural MRI in Huntington's disease and recommendations for its potential use in clinical trials.

Authors:  Nellie Georgiou-Karistianis; Rachael Scahill; Sarah J Tabrizi; Ferdinando Squitieri; Elizabeth Aylward
Journal:  Neurosci Biobehav Rev       Date:  2013-01-29       Impact factor: 8.989

8.  Functional magnetic resonance imaging of working memory in Huntington's disease: cross-sectional data from the IMAGE-HD study.

Authors:  Nellie Georgiou-Karistianis; Julie C Stout; Juan F Domínguez D; Sarah P Carron; Ayaka Ando; Andrew Churchyard; Phyllis Chua; India Bohanna; Alicia R Dymowski; Govinda Poudel; Gary F Egan
Journal:  Hum Brain Mapp       Date:  2013-08-02       Impact factor: 5.038

9.  In vivo evidence for the selective subcortical degeneration in Huntington's disease.

Authors:  Gwenaëlle Douaud; Timothy E Behrens; Cyril Poupon; Yann Cointepas; Saâd Jbabdi; Véronique Gaura; Narly Golestani; Pierre Krystkowiak; Christophe Verny; Philippe Damier; Anne-Catherine Bachoud-Lévi; Philippe Hantraye; Philippe Remy
Journal:  Neuroimage       Date:  2009-03-28       Impact factor: 6.556

10.  What does anisotropy measure? Insights from increased and decreased anisotropy in selective fiber tracts in schizophrenia.

Authors:  L M Alba-Ferrara; Gabriel A de Erausquin
Journal:  Front Integr Neurosci       Date:  2013-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.